#6 - Intuitive Surgical (NASDAQ:ISRG)
Intuitive Surgical Inc. (NASDAQ: ISRG) is a leader in robotic-assisted surgical systems. The company’s da Vinci robots are a popular choice among surgeons for their accuracy, flexibility, and the visualization they provide.
Robotic-assisted surgery is gaining acceptance. That acceptance comes at a price that could be impacted by higher interest rates. But that doesn’t seem to be the case for Intuitive Surgical, which is posting impressive year-over-year revenue and margin growth.
It’s also the reason why investors may want to wait for a better entry point before buying ISRG stock, which is up 34% in 2024. This has just pushed the company’s stock higher in the last 12 months, pushing it to the top of its 52-week range, and short interest has increased by 20% in the last month.
On the other hand, on July 19, 2024, analysts from Stifel Nicolas and JPMorgan Chase & Co. increased their price targets for ISRG stock to $475 and $495, respectively.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More - Current Price
- $537.80
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 14 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $513.74 (4.5% Downside)
